
Evotec Taps Novo Nordisk Executive Joanna Holbrook as Science Chief
Hamburg-based life sciences firm Evotec SE will install Dr. Joanna Holbrook as its new Chief Scientific Officer and member of the Management Board effective November 1, 2026. Holbrook arrives with a quarter-century of experience spanning pharmaceutical research, biotechnology leadership, and academic roles to oversee the company’s global innovation strategy.
























